Entrada Therapeutics, Inc. ($TRDA)
WENTWORTH KORY JAMES โ Chief Financial Officer
Shares
11,388
Price
$13.02
Total Value
$148,215.96
Nearby Earnings
Feb 26, 2026
EPS:Est: -1.32
Revenue:Est: $7.41M
Transaction Details
| Insider | WENTWORTH KORY JAMES |
|---|---|
| Title | Chief Financial Officer |
| Transaction Date | Mar 10, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Mar 11, 2026 |
| Shares Sold | 11,388 |
| Price per Share | $13.02 |
| Total Value | $148,215.96 |
| Shares Owned After | 121,510 |
| Derivative | No |
| Accession Number | 0001725663-26-000003 |
| Document | View SEC Filing |